Journal Article (Review Article) DZNE-2023-00358

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Exploring the ATN classification system using brain morphology.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2023
BioMed Central London

Alzheimer's research & therapy 15(1), 50 () [10.1186/s13195-023-01185-x]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: The NIA-AA proposed amyloid-tau-neurodegeneration (ATN) as a classification system for AD biomarkers. The amyloid cascade hypothesis (ACH) implies a sequence across ATN groups that patients might undergo during transition from healthy towards AD: A-T-N-➔A+T-N-➔A+T+N-➔A+T+N+. Here we assess the evidence for monotonic brain volume decline for this particular (amyloid-conversion first, tau-conversion second, N-conversion last) and alternative progressions using voxel-based morphometry (VBM) in a large cross-sectional MRI cohort.We used baseline data of the DELCODE cohort of 437 subjects (127 controls, 168 SCD, 87 MCI, 55 AD patients) which underwent lumbar puncture, MRI scanning, and neuropsychological assessment. ATN classification was performed using CSF-Aβ42/Aβ40 (A+/-), CSF phospho-tau (T+/-), and adjusted hippocampal volume or CSF total-tau (N+/-). We compared voxel-wise model evidence for monotonic decline of gray matter volume across various sequences over ATN groups using the Bayesian Information Criterion (including also ROIs of Braak stages). First, face validity of the ACH transition sequence A-T-N-➔A+T-N-➔A+T+N-➔A+T+N+ was compared against biologically less plausible (permuted) sequences among AD continuum ATN groups. Second, we evaluated evidence for 6 monotonic brain volume progressions from A-T-N- towards A+T+N+ including also non-AD continuum ATN groups.The ACH-based progression A-T-N-➔A+T-N-➔A+T+N-➔A+T+N+ was consistent with cognitive decline and clinical diagnosis. Using hippocampal volume for operationalization of neurodegeneration (N), ACH was most evident in 9% of gray matter predominantly in the medial temporal lobe. Many cortical regions suggested alternative non-monotonic volume progressions over ACH progression groups, which is compatible with an early amyloid-related tissue expansion or sampling effects, e.g., due to brain reserve. Volume decline in 65% of gray matter was consistent with a progression where A status converts before T or N status (i.e., ACH/ANT) when compared to alternative sequences (TAN/TNA/NAT/NTA). Brain regions earlier affected by tau tangle deposition (Braak stage I-IV, MTL, limbic system) present stronger evidence for volume decline than late Braak stage ROIs (V/VI, cortical regions). Similar findings were observed when using CSF total-tau for N instead.Using the ATN classification system, early amyloid status conversion (before tau and neurodegeneration) is associated with brain volume loss observed during AD progression. The ATN system and the ACH are compatible with monotonic progression of MTL atrophy.DRKS00007966, 04/05/2015, retrospectively registered.

Keyword(s): Humans (MeSH) ; Alzheimer Disease: diagnostic imaging (MeSH) ; Cross-Sectional Studies (MeSH) ; Bayes Theorem (MeSH) ; Amyloid beta-Peptides (MeSH) ; Cognitive Dysfunction: diagnostic imaging (MeSH) ; Brain: diagnostic imaging (MeSH) ; Amyloidogenic Proteins (MeSH) ; tau Proteins (MeSH) ; Biomarkers (MeSH) ; Alzheimer’s disease ; ATN ; Alzheimer’s disease ; Amyloid ; Biomarker ; MRI ; Memory ; VBM ; Voxel-based morphometry ; Amyloid beta-Peptides ; Amyloidogenic Proteins ; tau Proteins ; Biomarkers

Classification:

Note: CC BY

Contributing Institute(s):
  1. Clinical Neurophysiology and Memory (AG Düzel)
  2. Multimodal Neuroimaging (AG Maaß)
  3. Clinical Cognitive Neuroscience (AG Berron)
  4. Vascular Pathology (AG Dirnagl)
  5. Translational Neuropsychiatry (AG Priller)
  6. Interdisciplinary Dementia Research (AG Endres)
  7. Translational Dementia Research (Bonn) (AG Schneider)
  8. Patient Studies Bonn (Patient Studies Bonn)
  9. Molecular biomarkers for predictive diagnostics of neurodegenerative diseases (AG Wiltfang)
  10. Clinical Alzheimer’s Disease Research (AG Jessen)
  11. Vascular Cognitive Impairment & Post-Stroke Dementia (AG Dichgans)
  12. Parkinson Genetics (AG Gasser)
  13. Clinical Research Platform (CRP) (Clinical Research Platform (CRP))
  14. Clinical Dementia Research (Rostock /Greifswald) (AG Teipel)
  15. Interventional Trials and Biomarkers in Neurodegenerative Diseases (Biomarker)
  16. Molecular Neurobiology (AG Simons)
  17. Neuropsychology (AG Wagner)
  18. Mathematics, statistics and informatics methods for support of population studies and clinical research (AG Schmid Bonn)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)
  2. 351 - Brain Function (POF4-351) (POF4-351)
Experiment(s):
  1. Longitudinal Cognitive Impairment and Dementia Study

Appears in the scientific report 2023
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; DOAJ ; OpenAccess ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > BN DZNE > BN DZNE-Clinical Research Platform (CRP)
Institute Collections > BN DZNE > BN DZNE-Patient Studies (Bonn)
Institute Collections > BN DZNE > BN DZNE-AG Schmid Bonn
Document types > Articles > Journal Article
Institute Collections > GÖ DZNE > GÖ DZNE-AG Wiltfang
Institute Collections > BN DZNE > BN DZNE-AG Schneider
Institute Collections > ROS DZNE > ROS DZNE-AG Teipel
Institute Collections > TÜ DZNE > TÜ DZNE-AG Gasser
Institute Collections > BN DZNE > BN DZNE-AG Jessen
Institute Collections > MD DZNE > MD DZNE-AG Düzel
Institute Collections > MD DZNE > MD DZNE-AG Berron
Institute Collections > BN DZNE > BN DZNE-AG Wagner
Institute Collections > BN DZNE > BN DZNE-Biomarker
Institute Collections > M DZNE > M DZNE-AG Dichgans
Institute Collections > MD DZNE > MD DZNE-AG Maaß
Institute Collections > B DZNE > B DZNE-AG Priller
Institute Collections > B DZNE > B DZNE-AG Dirnagl
Institute Collections > M DZNE > M DZNE-AG Simons
Institute Collections > B DZNE > B DZNE-AG Endres
Full Text Collection
Public records
Publications Database

 Record created 2023-03-21, last modified 2024-08-26